Condition: Fabry Disease · Sponsor: Chiesi Farmaceutici S.p.A.
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents with Fabry Disease.
This description comes directly from the study's public registry record.
Chiesi Clinical Trial · +3905212791 · clinicaltrials_info@chiesi.com
Always discuss trial participation with your own doctor first.
| Phoenix Children's | Phoenix, Arizona, United States | Recruiting |
| Emory Genetics Clinical Trials Center | Atlanta, Georgia, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | Not Yet Recruiting |
| University of Utah | Salt Lake City, Utah, United States | Recruiting |
| Lysosomal and Rare Disorders Research and Treatment Center Inc | Fairfax, Virginia, United States | Not Yet Recruiting |
| UK für Kinder- und Jugendheilkunde der PMU Salzburg | Salzburg, Austria | Recruiting |
| Centre Hospitalier Universitaire (CHU) de Bordeaux - Groupe Hospitalier Pellegrin | Bordeaux, France | Recruiting |
| Hopital Arnaud de Villeneuve | Montpellier, France | Recruiting |
| Haukeland Universitetssjukehus | Bergen, Norway | Recruiting |
| Hospital Clinico Universitario De Santiago De Compostela | Santiago de Compostela, Spain | Recruiting |
| Great Ormond Street Hospital for Children NHS Foundation Trust | London, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06328608